Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions

Completed · Not applicable

Conditions studied: Herpes Zoster, Shingles, Genital Herpes

In brief

The objective of this study was to prove the bioequivalence of Valacyclovir Hydrochlorothiazide Caplet under fed conditions.

Key facts

Study ID

NCT01132716

Run by

Roxane Laboratories

People needed

48

Starts

2006-09-01

Expected to finish

2006-09-01

Last updated by the study team

2018-01-23

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening

You may not qualify if…

• Positive test for HIV, Hepatitis B, or Hepatitis C.
• Treatment with known enzyme altering drugs.
• History of allergic or adverse response to valacyclovir hydrochloride or any comparable or similar product.

Where it is running

• PRACs Institute, Ltd. — Fargo, North Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.